H.C. Wainwright Reiterates Buy Rating on Emergent BioSolutions (EBS)

March 26, 2026 6:45 AM

H.C. Wainwright analyst Raghuram Selvaraju reiterated a Buy rating and $12.00 price target on Emergent BioSolutions (NYSE: EBS).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found